Severe cases may require immediate action
Whilst a handful of enterovirus vaccines are available, including for poliovirus (PV) and for EV-A71 (frequently responsible for serious outcomes of hand, foot and mouth disease) 1,2,3,4 , there are as yet no licenced anti-enterovirus drugs, despite evidence for efficacy in clinical trials and reports of extremely high potency for compounds targeting a pocket internal to capsid protein VP1 (termed here the P site) 5,6
Semaglutide commonly causes nausea, vomiting, constipation, and appetite suppressionusually mild and temporary
The animal science is solid, but no large human trials have been completed, it's not FDA-approved, and the company that developed it walked away from it in the early 2000s
Mov Disord (2014) 29:158390